|
|
|||
|
||||
OverviewA comprehensive and authoritative analysis of the commercial use of some of the most valuable natural resources: genetic material, the basis of many vital industries - pharmaceuticals, agriculture, cosmetics and more. Use of the material involves stakeholders in many different countries and is governed by the International Convention on Biological Diversity (ICBD). Chapters review available resources, demand and markets, costs of development, benefits, and examples of best practice in benefit sharing and successful partnerships. It covers the whole commercial chain from the collection of raw material to product development. Full Product DetailsAuthor: Kerry Ten Kate , Sarah A. LairdPublisher: Taylor & Francis Ltd Imprint: Earthscan Ltd Dimensions: Width: 21.90cm , Height: 2.80cm , Length: 27.60cm Weight: 1.319kg ISBN: 9781853833342ISBN 10: 1853833347 Pages: 398 Publication Date: 01 August 1999 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Out of Print Availability: Out of stock Table of ContentsList of Boxes, Figures and Tables * Acronyms and Abbreviations * Foreword * Acknowledgements * Introduction * Regulating Access to Genetic Resources and Benefit-Sharing: the Legal Aspects * Natural Products and the Pharmaceutical Industry * The Botanical Medicine Industry * The Development of Major Crops by the Seed Industry * Horticulture * Crop Protection * Biotechnology in Fields other than Healthcare and Agriculture * The Natural Personal Care and Cosmetics Industry * Industry and the CBD * Conclusions * Recommendations * Appendix A The Influence of Natural products on 1997 Pharmaceutical Sales Figures * Appendix B Scientific and Common Names of Selected Botanical Medicines * Appendix C Regulatory Frameworks for Botanical Medicines * Appendix D Tentative List of Crops Under Negotiation as the Scope of the Multilateral System in the Revised International Undertaking * Appendix E Regulatory Frameworks Relevant to the Release of Crop Varieties * Useful Contacts and Sources of Information * Glossary * Bibliography * Research Methodology and Team * IndexReviews'Written by two of the world's leading authorities on the commercial use of biodiversity, this book is an invaluable resource and guide for further research. It is as practical as it is informative and should be in the hands of everyone interested in the state and fate of the world's living resources' Professor Calestous Juma, Harvard University 'Full of examples from which we can learn... this will be an invaluable resource to policy-makers, organizations studying and creating uses for genetic resources and the companies which wish to develop them' from the Foreword by Professor Sir Ghillean Prance, ex-Director, Kew Gardens and Sir Richard Sykes, ex-Chairman, Glaxo Wellcome Author InformationKerry ten Kate is Policy Adviser for the Directorate of, and Sarah Laird is Independent Consultant for the Convention on Biodiversity Unit at, the Royal Botanic Gardens, Kew Tab Content 6Author Website:Countries AvailableAll regions |